| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Jul 01, 2025 | Sale | $16.99 | 15,000 | 254,860 | 10,315 | Jul 03, 2025, 04:21 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Jul 01, 2025 | Option/RSU Exercise | $1.50 | 15,000 | 22,500 | 25,315 | Jul 03, 2025, 04:21 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Jun 18, 2025 | Option/RSU Exercise | $1.50 | 15,000 | 22,500 | 22,696 | Jun 20, 2025, 06:38 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Jun 18, 2025 | Sale | $16.00 | 15,000 | 240,000 | 7,696 | Jun 20, 2025, 06:38 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Mar 20, 2025 | Option/RSU Exercise | $1.50 | 10,000 | 15,000 | 17,696 | Mar 21, 2025, 06:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Mar 20, 2025 | Sale | $14.00 | 10,000 | 140,000 | 7,696 | Mar 21, 2025, 06:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Dec 02, 2024 | Option/RSU Exercise | $1.50 | 3,717 | 5,576 | 9,410 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Dec 02, 2024 | Sale | $14.11 | 3,717 | 52,461 | 5,693 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Dec 04, 2024 | Option/RSU Exercise | $1.50 | 6,283 | 9,425 | 11,976 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Dec 04, 2024 | Sale | $14.00 | 6,283 | 87,962 | 5,693 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Sep 18, 2024 | Sale | $14.00 | 10,000 | 140,000 | 5,693 | Sep 19, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Sep 18, 2024 | Option/RSU Exercise | $1.50 | 10,000 | 15,000 | 15,693 | Sep 19, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Aug 19, 2024 | Option/RSU Exercise | $1.50 | 10,000 | 15,000 | 15,693 | Aug 21, 2024, 06:51 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Eric Karas | Chief Commercial Officer | Aug 19, 2024 | Sale | $14.00 | 10,000 | 140,000 | 5,693 | Aug 21, 2024, 06:51 PM |